4.5 Article

Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer

Caroline E. Nunes-Xavier et al.

Summary: This study revealed heterogeneous expression of PDH complex components in PCa tumors, with PDH complex components being related to AR signaling and PDK2 expression associated with poor PCa prognosis. These findings highlight the potential of targeting PDH complex components for intervention in PCa.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

MVP Expression Facilitates Tumor Cell Proliferation and Migration Supporting the Metastasis of Colorectal Cancer Cells

Paulina Pietras et al.

Summary: Cancer cells exhibit significant dysregulation of gene expression, with MVP playing a crucial role in regulating proliferation and migration, potentially facilitating metastasis of colon cancer; MVP and TEP1 contribute to resistance to vinorelbine, while vPARP does not.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer

Hakon Ramberg et al.

Summary: The study identified MVP as a potential prognostic biomarker for prostate cancer patients, with high levels associated with increased risk of death from the disease. The addition of MVP onto existing risk parameters like CAPRA-S score showed improved prediction of patient outcomes.

CARCINOGENESIS (2021)

Article Biochemistry & Molecular Biology

Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade

Wei Wang et al.

Summary: The study identified a novel mechanism regulating HH-independent GLI1 expression in chondrosarcoma, involving the MVP protein and the mTOR/S6K1 signaling cascade. Inhibition of MVP and GLI1 together strongly suppressed tumor growth in vitro and in vivo. This finding provides a rationale for combination therapy in advanced chondrosarcoma patients.

CELL DEATH AND DIFFERENTIATION (2021)

Review Oncology

The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy

Gianni Frascotti et al.

Summary: The vault nanoparticle is a eukaryotic ribonucleoprotein complex consisting of 78 individual 97 kDa-major vault protein (MVP) molecules that form two symmetrical, cup-shaped, hollow halves. It plays diverse cellular functions including protection against cellular stresses and activation of prosurvival signaling pathways. Its biological roles in physiological and pathological processes may provide new insights for its utilization as a nanocarrier for drug delivery.

CANCERS (2021)

Article Multidisciplinary Sciences

Immunoediting role for major vault protein in apoptotic signaling induced by bacterial N-acyl homoserine lactones

Josep Rayo et al.

Summary: The major vault protein plays a key role in cellular resistance to chemotherapy, inflammatory responses, and apoptotic signaling. The study identifies N-(3-oxo-dodecanoyl) homoserine lactone as a target of MVP and shows that it can modulate cell survival and death by regulating signaling pathways.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Endocrinology & Metabolism

Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer

Caroline E. Nunes-Xavier et al.

Summary: This study identified distinct clinical relevance of the two immune checkpoint proteins PD-L1 and B7-H3 in prostate cancer, with B7-H3 potentially serving as a significant therapeutic target.

PROSTATE (2021)

Article Medicine, Research & Experimental

Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition

Lichan Yuan et al.

Summary: The study revealed that MVP acts as a negative regulator of osteoclastogenesis, inhibiting bone resorption and potentially serving as a therapeutic target for preventing bone loss.

THERANOSTICS (2021)

Review Biochemistry & Molecular Biology

Major vault protein plays important roles in viral infection

Wei Wang et al.

IUBMB LIFE (2020)

Article Oncology

YB-1: The key to personalised prostate cancer management?

Mark Bates et al.

CANCER LETTERS (2020)

Review Biochemistry & Molecular Biology

The role of protein tyrosine phosphatases in prostate cancer biology

Caroline E. Nunes-Xavier et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Multidisciplinary Sciences

MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression

Yun Teng et al.

NATURE COMMUNICATIONS (2017)

Review Medicine, Research & Experimental

Prostate cancer, PI3K, PTEN and prognosis

Helen M. Wise et al.

CLINICAL SCIENCE (2017)

Review Oncology

MVP and vaults: a role in the radiation response

Pedro C. Lara et al.

RADIATION ONCOLOGY (2011)

Review Biochemistry & Molecular Biology

Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity

W. Berger et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2009)

Review Pharmacology & Pharmacy

Cellular functions of vaults and their involvement in multidrug resistance

E. Steiner et al.

CURRENT DRUG TARGETS (2006)

Review Biochemistry & Molecular Biology

The vault complex

A van Zon et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2003)

Article Biochemistry & Molecular Biology

PTEN associates with the vault particles in HeLa cells

ZB Yu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)